Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinaemia: Further evidence of inflammatory activation

Heart

Volumn 90, Issue 12, 2004, Pages 1438-1442

  Sampietro, Tiziana ^a,b   Bigazzi, F ^b   Dal Pino, B ^b   Rossi, G ^b   Chella, E ^b   Lusso, S ^b   Puntoni, M ^b   Tuoni, M ^b   Bionda, A ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPLEMENT SYSTEM; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FAMILIAL DISEASE; FAMILIAL HYPOALPHALIPOPROTEINEMIA; FEMALE; HUMAN; HYPOLIPOPROTEINEMIA; IMMUNE SYSTEM; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

APOLIPOPROTEIN A-I; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COMPLEMENT C3; COMPLEMENT C3C; COMPLEMENT C4; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; TANGIER DISEASE; TRIGLYCERIDES; UP-REGULATION;

EID: 10344229927     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.017327     Document Type: Article

References (21)

1. Sampietro T, Bigazzi F, Dal Pino B, et al. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition? Circulation 2002;105:11-4.
2. Wolbink GJ, Brouwer MC, Buysmann S, et al. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 1996;157:473-9.
3. Yeh ET, Andersen HV, Pasceri V, et al. C-reactive protein: linking inflammation to cardiovascular complications. Circulation 2001;104:974-5.
4. Lagrand WK, Niessen HW, Nijmeijer R, et al. Role for complement as an intermediate between C-reactive protein and intercellular adhesion molecule-1 expression? Circulation 2001;104:E46.
5. Pang AA, Katz A, Minta JO. C3 deposition in cholesterol-induced atherosclerosis in rabbits: a possible etiologic role for complement in atherogenesis. J Immunol 1979;123:1117-22.
6. Smith EB. The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lipid Res 1974;12:1-49.
7. Seifert PS, Kazatchkine MD. The complement system in atherosclerosis. Atherosclerosis 1988;73:91-104.
8. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
9. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
10. Seifert PS, Hugo F, Tranum-Jensen J, et al. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions. J Exp Med 1990;172:547-57.
11. Hollander W, Colombo MA, Kirkpatrick B, et al. Soluble proteins in the human atherosclerotic plaque: with spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. Atherosclerosis 1979;34:391-405.
12. Vlaicu R, Rus HG, Niculescu F, et al. Immunoglobulins and complement components in human aortic atherosclerosis intima. Atherosclerosis 1985;55:35-50.
13. Niculescu F, Hugo F, Rus HG, et al. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic plaques. Clin Exp Immunol 1987;69:477-83.
14. Kilgore KS, Shen JP, Miller BF, et al. Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E selectin and ICAM-1. J Immunol 1995;155:1434-41.
15. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-44.
16. Niessen HW, Lagrand WK, Visser CA, et al. Deregulation of ICAM-1 on cardiomyocytes in jeapardized human myocardium during infarction. Cardiovasc Res 1999;41:603-10.
17. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
18. Posten RN, Haskard LO, Coucher JR, et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992;140:665-73.
19. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. lancet 1998;351:88-92.
20. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.
21. Friedewald WT, Levy RR, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.